Setting the Stage for Cardiac Contractility Modulation – From Screening to Implant (Case-Based Approach)

November 25, 2021

This video will introduce CCM® therapy through the eyes of implanting electrophysiologists. Using their own clinical cases, the program faculty will discuss the screening process for eligible CCM® patients, the implant procedure, lead placement, and patient follow-up. Each faculty member will share their personal experience with cardiac contractility modulation and their individual patient responses to the therapy. The session will allow time for a question-and-answer segment to encourage an interactive approach.

  • October 26, 2021 - U.S. Food and Drug Administration approved a modification of labeling for the Optimizer® Smart medical device, allowing the removal of “normal sinus rhythm” (NSR) from the indications for use statement as of 10/26/2021. Please note that this presentation was done prior to this FDA update.
Login to view comments. Click here to Login